Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.3928.99-10.0912.99274.74

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is -5.39 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.39
Mar202428.99
Mar2023-10.09
Mar202212.99
Mar2021274.74

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.39
Negative
Mar2024 28.99
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹114.4 Cr -0.8% 3.4% -18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,879.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹166,620.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,431.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,070.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹107,051.0 Cr 0.3% -1.3% -9% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-0.8%

3.4%

-18.8%

SENSEX

-5%

-9.6%

3.1%


You may also like the below Video Courses